Paul D. Leger

Hematology
3800 Reservoir Rd NW
Washington, DC 20007

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 23 publications

Anti-PD-(L)1 plus chemotherapy in advanced PD-L1-negative nonsquamous non-small cell lung cancer: a systematic review and meta-analysis.

Anti-PD-(L)1 plus chemotherapy in advanced PD-L1-negative nonsquamous non-small cell lung cancer: a systematic review and meta-analysis.

Journal: Immunotherapy
Published: July 03, 2026

Timing and Resolution of Bothersome Hot Flashes Following Short Course Oral Gonadotropin-Releasing Hormone Receptor Antagonist Relugolix, and Stereotactic Body Radiotherapy for Localized Prostate Cancer.

Timing and Resolution of Bothersome Hot Flashes Following Short Course Oral Gonadotropin-Releasing Hormone Receptor Antagonist Relugolix, and Stereotactic Body Radiotherapy for Localized Prostate Cancer.

Journal: Cureus
Published: February 22, 2026

Asymptomatic Cervical Cancer Recurrence Presenting As Gastric Metastasis: A Report of a Rare Case.

Asymptomatic Cervical Cancer Recurrence Presenting As Gastric Metastasis: A Report of a Rare Case.

Journal: Cureus
Published: January 01, 2026

A multi-perspective study assessing Black and African American participation barriers in prostate cancer clinical trials.

A multi-perspective study assessing Black and African American participation barriers in prostate cancer clinical trials.

Journal: Future oncology (London, England)
Published: February 24, 2025

Utilization of patient-reported outcomes to assess adherence to relugolix when combined with stereotactic body radiation therapy for intermediate to high-risk prostate cancer.

Utilization of patient-reported outcomes to assess adherence to relugolix when combined with stereotactic body radiation therapy for intermediate to high-risk prostate cancer.

Journal: Frontiers in oncology
Published: December 05, 2024

Maintenance of patient-reported health-related quality of life post neoadjuvant relugolix prior to the initiation of prostate radiation therapy.

Maintenance of patient-reported health-related quality of life post neoadjuvant relugolix prior to the initiation of prostate radiation therapy.

Journal: Frontiers in oncology
Published: September 15, 2024

The impact of neoadjuvant relugolix on multi-dimensional patient-reported fatigue.

The impact of neoadjuvant relugolix on multi-dimensional patient-reported fatigue.

Journal: Frontiers in oncology
Published: April 05, 2024

Bothersome Hot Flashes Following Neoadjuvant Androgen Deprivation Therapy and Stereotactic Body Radiotherapy for Localized Prostate Cancer.

Bothersome Hot Flashes Following Neoadjuvant Androgen Deprivation Therapy and Stereotactic Body Radiotherapy for Localized Prostate Cancer.

Journal: Cureus
Published: March 06, 2024

Impact of neoadjuvant relugolix on patient-reported sexual function and bother.

Impact of neoadjuvant relugolix on patient-reported sexual function and bother.

Journal: Frontiers in oncology
Published: January 26, 2024

Early biochemical outcomes following neoadjuvant/adjuvant relugolix with stereotactic body radiation therapy for intermediate to high risk prostate cancer.

Early biochemical outcomes following neoadjuvant/adjuvant relugolix with stereotactic body radiation therapy for intermediate to high risk prostate cancer.

Journal: Frontiers in oncology
Published: September 05, 2023

Benefits, challenges, and usability evaluation of DeloreanJS: a back-in-time debugger for JavaScript.

Benefits, challenges, and usability evaluation of DeloreanJS: a back-in-time debugger for JavaScript.

Journal: PeerJ. Computer science
Published: October 05, 2022

DSSM: Distributed Streaming Data Sharing Manager.

DSSM: Distributed Streaming Data Sharing Manager.

Journal: Sensors (Basel, Switzerland)
Published: January 12, 2021
Showing 1-12 of 23

Last Updated: 09/26/2026